Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong performance from ...
We are advised by Bright Meds that journalists and other readers should disregard the news release, "Brightmeds Tirzepatide Investigated: Is It Safe and Legit for Weight Loss? Exploring Safety, Side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results